… Sarcopenic obesity is a clinical disorder characterized … sarcopenia will rise as the prevalence
of obesity continues to increase at an unparallel rate. Recently, sarcopenia and sarcopenic …

… Sarcopenia is an important public health problem, … ) neuromusculoskeletal approach to
sarcopenia. In addition, under … in the special interest group on sarcopenia (ISarcoPRM). The …

… patients at risk for malnutrition, sarcopenia, and frailty. Therefore, identification of a
dialysis-responsive, functionally relevant complication of CKD has important implications. Although …

… sarcopenia, albumin, and 6MWD in a cohort of LTx patients and analyzed the utility of these
as markers of outcomes for LTx patients… patients may have been taking steroids or antifibrotic …

… factors, gene therapies, cell therapies, and antifibrotic agents aim … Thus, senolytic treatment
prior to autologous PPP treatments may … in fibrosis, especially in aged or sarcopenic patients. …

… Frailty is a phenotype characterized by lower lean muscle mass (sarcopenia), … of sarcopenia
and frailty experienced by pediatric cancer survivors can be delayed by optimizing patient-…

… patients is closely related to the fibrotic stage (13) and is the strongest predictor of mortality in
MAFLD patients (… 1) and explore effective antifibrotic therapeutic strategies. From metabolic …

… Agents that counteract the actions of transforming growth factor beta 1 have been
investigated as potential antifibrotic medications and as adjunct treatment to platelet-rich plasma …

… Malnutrition is closely associated with progression of sarcopenia and … to antifibrotic therapy
might have had an effect on the small number of patients treated with antifibrotic therapy in …

… sarcopenia screening have been used by AWGS 2019. The aim of this study was to assess
accuracy of these three sarcopenia screening tools in patients … by treatment (eg, antifibrotic …